News | May 19, 2023
Venus Remedies recognized for R&D excellence by DSIR
Leading Research-driven Pharma Company Combats Antibiotic Resistance and Demonstrates Innovation in Medical Solutions
Leading Research-driven Pharma Company Combats Antibiotic Resistance and Demonstrates Innovation in Medical Solutions
SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
Products offered on a not-for-profit basis to the 45 lower-income countries now include the full portfolio for which Pfizer has global rights.
It offers quick relief in various types of Coughs, Colds and Sore Throat,
It serves to leverage the strengths of various institutions to coordinate AMR surveillance lab networks
Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes
This first joint plan on One Health aims to create a framework to integrate systems and capacity so that we can collectively better prevent, predict, detect, and respond to health threats
Subscribe To Our Newsletter & Stay Updated
